Skip to content

Clinical trials

Phase 3 Stroke trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: United Kingdom Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20033
20055
20062
20073
20082
20093
20101
20111
20122
20137
20142
20151
20161
20173
20182
20192
20212
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated8
Recruiting5
Active, not recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Novartis Pharmaceuticals4
AstraZeneca3
Boehringer Ingelheim2
Janssen Research & Development, LLC2
Pfizer2
St George's, University of London2
The George Institute2
University of Nottingham2
University of Oxford2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke49
Myocardial Infarction14
Cardiovascular Diseases11
Atrial Fibrillation8
Ischemic Stroke7
Ischemic Attack, Transient6
Coronary Artery Disease4
Heart Diseases4
Peripheral Arterial Disease4
Acute Coronary Syndrome3

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.